Biopharma

France’s Sanofi to Buy US Biopharma Firm Kadmon in $1.9 Billion Deal

PARIS—French drugmaker Sanofi said on Wednesday it would buy U.S. biopharmaceutical company Kadmon Holdings for 1.9 billion dollars, one month after announcing the purchase of another US biotech, Translate Bio, ...

September 8, 2021BY Reuters
Chinese Using Unfair Practices to Challenge US Dominance in Biopharma, Report Says

The Chinese regime is seeking to challenge U.S. dominance in biopharma by using a range of unfair means, ...

August 21, 2019BY Cathy He
Pfizer to Buy Array BioPharma in Deal Worth $11.4 Billion

Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug ...

June 17, 2019BY The Associated Press
GE Sells Biopharma Unit for $21 Billion

BOSTON—General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as it continues to sell ...

February 25, 2019BY The Associated Press